American Gastroenterological Association technical review on the management of Barrett's esophagus
The aim of evidence-based medicine is to improve the quality of health care by integrating
the best research evidence with clinical expertise and patient values. Evidence-based …
the best research evidence with clinical expertise and patient values. Evidence-based …
Barrett esophagus and risk of esophageal cancer: a clinical review
SJ Spechler - Jama, 2013 - jamanetwork.com
Importance Barrett esophagus, a complication of gastroesophageal reflux disease (GERD),
predisposes patients to esophageal adenocarcinoma, a tumor that has increased in …
predisposes patients to esophageal adenocarcinoma, a tumor that has increased in …
Diagnosis and management of Barrett's esophagus: an updated ACG guideline
Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …
Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus
KK Wang, RE Sampliner - Official journal of the American College …, 2008 - journals.lww.com
The guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus were
originally published by the American College of Gastroenterology in 1998 and updated in …
originally published by the American College of Gastroenterology in 1998 and updated in …
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis
Background and aims Acid-suppressive medications, particularly proton pump inhibitors
(PPIs), may decrease the risk of oesophageal adenocarcinoma (OAC) in patients with …
(PPIs), may decrease the risk of oesophageal adenocarcinoma (OAC) in patients with …
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
The public health importance of Barrett's oesophagus lies in its association with
oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at …
oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at …
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop
P Sharma, K McQuaid, J Dent, MB Fennerty… - Gastroenterology, 2004 - Elsevier
Background & Aims: The diagnosis and management of Barrett's esophagus (BE) are
controversial. We conducted a critical review of the literature in BE to provide guidance on …
controversial. We conducted a critical review of the literature in BE to provide guidance on …
Barrett's esophagus
SJ Spechler - New England Journal of Medicine, 2002 - Mass Medical Soc
A 55-year-old man has had frequent heartburn for more than 10 years. Endoscopy reveals
columnar epithelium lining the distal 5 cm of the esophagus. Biopsy specimens show …
columnar epithelium lining the distal 5 cm of the esophagus. Biopsy specimens show …
Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus
BACKGROUND & AIMS: Acid exposure contributes to the development of Barrett's
esophagus (BE) and its progression toward esophageal adenocarcinoma. Patients with BE …
esophagus (BE) and its progression toward esophageal adenocarcinoma. Patients with BE …
Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus
HB El-Serag, TV Aguirre, S Davis… - Official journal of the …, 2004 - journals.lww.com
METHODS: We analyzed prospectively collected data by a single endoscopist on patients
with BE in a VA (Veterans Affairs) setting over a 20-yr time period (1981–2000). A …
with BE in a VA (Veterans Affairs) setting over a 20-yr time period (1981–2000). A …